Phase
Condition
Obsessive-compulsive Disorder
Treatment
Exposure & Response Prevention (EX/RP)
Clinical Study ID
Ages 18-45 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Diagnosis of OCD;
Male and female subjects aged between 18- 45;
Women must be menstruating and regularly cycling
Ability to tolerate a treatment-free period;
No psychotropic medication in the past 12 weeks
At entry, at least moderate severity OCD
Willingness and ability to give written informed consent after full explanation ofstudy procedures.
Exclusion
Exclusion Criteria:
Use of birth control (oral contraception or IUD) that affects the menstrual cycle,or menopause.
Pregnancy. Women of childbearing potential will be required to sign a statementindicating their intention to avoid pregnancy during the study.
Neurologic or medical condition that would prevent safe participation in the fullstudy protocol.
Any contradiction to magnetic resonance imaging (e.g., metallic implants ordevices).
Comorbid psychiatric conditions that significantly elevate the risks associated withstudy participation or confound results.
Patients with prominent suicidal ideation or with a recent suicide attempt.
Current psychotherapy
Study Design
Study Description
Connect with a study center
New York State Psychiatric Institute
New York, New York 10032
United StatesSuspended
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.